Effect of clarithromycin on the pharmacokinetics of 2',3'-dideoxyinosine in patients who are seropositive for human immunodeficiency virus.
Gillum
J G
JG
Department of Pharmacy and Pharmaceutics, Medical College of Virginia/Virginia Commonwealth University, Richmond, USA.
Bruzzese
V L
VL
Israel
D S
DS
Kaplowitz
L G
LG
Polk
R E
RE
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics*; D017291:Clarithromycin / Q000493:pharmacokinetics*; D016049:Didanosine / Q000493:pharmacokinetics*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D018894:Reverse Transcriptase Inhibitors / Q000493:pharmacokinetics*
D000900:Anti-Bacterial Agents; D018894:Reverse Transcriptase Inhibitors; D017291:Clarithromycin; D016049:Didanosine